rxstatShortages › Insulin Semi Synthetic Human

Insulin Semi Synthetic Human shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Insulin Semi Synthetic Human products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
5

Reports by product

Discontinued
HUMULIN R
100UNIT · SOLUTION · ELI LILLY CANADA INC
DIN 00586714
Resolved
HUMULIN R
100UNIT · SOLUTION · ELI LILLY CANADA INC
DIN 00586714 · ended Oct 21, 2024 · Demand increase for the drug.
Discontinued
HUMULIN R
100UNIT · SOLUTION · ELI LILLY CANADA INC
DIN 00586714
Resolved
HUMULIN R
100UNIT · SOLUTION · ELI LILLY CANADA INC
DIN 00586714 · ended Sep 17, 2024 · Demand increase for the drug.
Resolved
HUMULIN R
100UNIT · SOLUTION · ELI LILLY CANADA INC
DIN 00586714 · ended Apr 23, 2024 · Other (Please describe in comments)

What's happening

One or more Insulin Semi Synthetic Human products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Insulin Semi Synthetic Human is classified under “INSULINS AND ANALOGUES” (ATC A10AB).

Recent changes

Common questions

When will Insulin Semi Synthetic Human be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Insulin Semi Synthetic Human in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (insulins and analogues)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.